News
-
IMI launches €130 million calls for proposals
On 19 July, the Innovative Medicines Initiative (IMI) launched two new Calls for proposals (Call 11 and Call 12) with topics regarding Alzheimer’s disease, big data, vaccines, autoimmune disease, the blood-brain barrier, drug development, and the exploitation of IMI project results with a total budget of over € 130 million.
-Read more-
-
EPSCO informal meeting
On 20 July an informal meeting of EPSCO (Employment, Social Policy, Health and Consumer Affairs Council configuration) in Tallinn, the EU ministers for health discussed the future of digital solutions in health.
-Read more-
-
Commission to invest €97 million to help 64 small businesses bring their innovations to the market
On 17 July the European Commission announced that 64 small and medium-sized companies (SMEs) from 16 countries were selected for funding in the Phase 2 of the Horizon 2020 SME Instrument.
-Read more-
-
Development and lifecycle of personalised medicines and companion diagnostics
On 28 July, the European Medicines Agency (EMA) released a concept paper on personalised medicine for public consultation.
-Read more-
-
Public consultation on Health and Care in the Digital Single Market
On 20 July, the European Commission launched a public consultation on Health and Care in the Digital Single Market.
-Read more-
-
FDA confirms its investment in modeling and simulation for improving drug development
Scott Gottlieb commissioner of the USA Food & Drug Administration has recently written an article for the FDA Blog “FDA Voice” on the impact of the 21st Century Cures Act, which authorised $6.3 billion in additional funding, part of which is dedicated to research and drug development.
-Read more-
